These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12594221)

  • 1. Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs.
    Eblen ST; Kumar NV; Shah K; Henderson MJ; Watts CK; Shokat KM; Weber MJ
    J Biol Chem; 2003 Apr; 278(17):14926-35. PubMed ID: 12594221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying specific kinase substrates through engineered kinases and ATP analogs.
    Kumar NV; Eblen ST; Weber MJ
    Methods; 2004 Apr; 32(4):389-97. PubMed ID: 15003601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
    Eblen ST; Catling AD; Assanah MC; Weber MJ
    Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction.
    Vomastek T; Iwanicki MP; Burack WR; Tiwari D; Kumar D; Parsons JT; Weber MJ; Nandicoori VK
    Mol Cell Biol; 2008 Nov; 28(22):6954-66. PubMed ID: 18794356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
    Zhang J; Zhou B; Zheng CF; Zhang ZY
    J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel substrates of MAP Kinase cascades using bioengineered kinases that uniquely utilize analogs of ATP to phosphorylate substrates.
    Zheng H; Al-Ayoubi A; Eblen ST
    Methods Mol Biol; 2010; 661():167-83. PubMed ID: 20811983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation by ETV3.
    Carlson SM; Chouinard CR; Labadorf A; Lam CJ; Schmelzle K; Fraenkel E; White FM
    Sci Signal; 2011 Oct; 4(196):rs11. PubMed ID: 22028470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Src family protein kinases with unnatural nucleotide specificity.
    Liu Y; Shah K; Yang F; Witucki L; Shokat KM
    Chem Biol; 1998 Feb; 5(2):91-101. PubMed ID: 9495830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
    Burkhard KA; Chen F; Shapiro P
    J Biol Chem; 2011 Jan; 286(4):2477-85. PubMed ID: 21098038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1α.
    Karapetsas A; Giannakakis A; Pavlaki M; Panayiotidis M; Sandaltzopoulos R; Galanis A
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1582-90. PubMed ID: 21807114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural assembly of the signaling competent ERK2-RSK1 heterodimeric protein kinase complex.
    Alexa A; Gógl G; Glatz G; Garai Á; Zeke A; Varga J; Dudás E; Jeszenői N; Bodor A; Hetényi C; Reményi A
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2711-6. PubMed ID: 25730857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of the extracellular signal-regulated kinase 2 is regulated by differential phosphorylation in the activation loop.
    Zhou B; Zhang ZY
    J Biol Chem; 2002 Apr; 277(16):13889-99. PubMed ID: 11839761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel extracellular signal-regulated kinase docking domain inhibitors.
    Hancock CN; Macias A; Lee EK; Yu SY; Mackerell AD; Shapiro P
    J Med Chem; 2005 Jul; 48(14):4586-95. PubMed ID: 15999996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2.
    Piserchio A; Warthaka M; Kaoud TS; Callaway K; Dalby KN; Ghose R
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6287-E6296. PubMed ID: 28716922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA aptamers as pathway-specific MAP kinase inhibitors.
    Seiwert SD; Stines Nahreini T; Aigner S; Ahn NG; Uhlenbeck OC
    Chem Biol; 2000 Nov; 7(11):833-43. PubMed ID: 11094337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5'-triphosphate.
    Robinson MJ; Harkins PC; Zhang J; Baer R; Haycock JW; Cobb MH; Goldsmith EJ
    Biochemistry; 1996 May; 35(18):5641-6. PubMed ID: 8639522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinetic approach towards understanding substrate interactions and the catalytic mechanism of the serine/threonine protein kinase ERK2: identifying a potential regulatory role for divalent magnesium.
    Waas WF; Rainey MA; Szafranska AE; Cox K; Dalby KN
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):81-7. PubMed ID: 15023352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.
    Bourguignon LY; Gilad E; Rothman K; Peyrollier K
    J Biol Chem; 2005 Mar; 280(12):11961-72. PubMed ID: 15655247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the serine/threonine protein kinase Raf-1 to utilise an orthogonal analogue of ATP substituted at the N6 position.
    Hindley AD; Park S; Wang L; Shah K; Wang Y; Hu X; Shokat KM; Kolch W; Sedivy JM; Yeung KC
    FEBS Lett; 2004 Jan; 556(1-3):26-34. PubMed ID: 14706820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.